Free Trial
→ Is Elon's empire crumbling? (From Brownstone Research) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BLEU
bleuacacia
$11.03
$11.05
$10.70
▼
$11.59
$83.39M0.013,053 shsN/A
CAEP
Cantor Equity Partners III
$10.55
+0.7%		$0.00
$10.30
▼
$11.09
$320.48MN/A223,298 shs35,095 shs
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
$10.81
-1.2%		$11.33
$9.90
▼
$12.24
$314.67MN/A234,064 shs311,395 shs
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
$10.40
+0.2%		$10.38
$9.95
▼
$11.20
$328.27MN/A5,642 shs3,859 shs
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BLEU
bleuacacia
0.00%0.00%0.00%0.00%+1.66%
CAEP
Cantor Equity Partners III
+0.67%-1.77%+1,054,999,900.00%+1,054,999,900.00%+1,054,999,900.00%
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
-1.19%-2.44%-2.70%-0.09%+1,080,999,900.00%
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
0.00%0.00%+0.10%+1.07%+1,039,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BLEU
bleuacacia
N/AN/AN/AN/AN/AN/AN/AN/A
CAEP
Cantor Equity Partners III
N/AN/AN/AN/AN/AN/AN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BLEU
bleuacacia
0.00
N/AN/AN/A
CAEP
Cantor Equity Partners III
0.00
N/AN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
0.00
N/AN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BLEU
bleuacacia
N/AN/A$0.56 per share19.70($1.64) per shareN/A
CAEP
Cantor Equity Partners III
N/AN/AN/AN/AN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/AN/AN/AN/AN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BLEU
bleuacacia
$3.86MN/A58.05∞N/AN/A-6.04%4.62%N/A
CAEP
Cantor Equity Partners III
N/AN/A0.00∞N/AN/AN/AN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/AN/A0.00∞N/AN/AN/AN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/AN/A0.00∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BLEU
bleuacacia
N/AN/AN/AN/AN/A
CAEP
Cantor Equity Partners III
N/AN/AN/AN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/AN/AN/AN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BLEU
bleuacacia
N/A
0.04
0.04
CAEP
Cantor Equity Partners III
N/AN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/AN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BLEU
bleuacacia
13.89%
CAEP
Cantor Equity Partners III
N/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/A

Insider Ownership

CompanyInsider Ownership
BLEU
bleuacacia
0.94%
CAEP
Cantor Equity Partners III
N/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BLEU
bleuacacia
47.56 million7.49 millionNot Optionable
CAEP
Cantor Equity Partners III
230.58 millionN/AN/A
HCM II Acquisition Corp. stock logo
HOND
HCM II Acquisition
N/A28.75 millionN/AN/A
Voyager Acquisition Corp. stock logo
VACH
Voyager Acquisition
N/A31.62 millionN/AN/A

Recent News About These Companies

VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/17/3117234/0/en/veraxa-biotech-and-voyager-acquisition-corp-announce-filing-of-form-f-4-registration-statement-with-the-sec.html
Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
July 17, 2025  |  pharmiweb.comP
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/17/3116951/0/en/veraxa-biotech-and-voyager-acquisition-corp-announce-filing-of-form-f-4-registration-statement-with-the-sec.html
Wealthspring Capital LLC Sells 24,668 Shares of Voyager Acquisition Corp. (NASDAQ:VACH)
July 15, 2025  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wealthspring-capital-llc-sells-24668-shares-of-voyager-acquisition-corp-nasdaqvach-2025-07-15/
VACH Voyager Acquisition Corp. - Seeking Alpha
July 10, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/VACH
Voyager Acquisition Corp. Cl A (VACH) Stock Price Today - WSJ
June 27, 2025  |  wsj.comhttps://www.wsj.com/market-data/quotes/VACH
Space Firm Voyager Technologies Surges 139% After Upsized IPO
June 11, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/space-firm-voyager-technologies-surges-139-after-upsized-ipo/ar-AA1GwICo
Voyager launches IPO with $1.6 billion valuation target
June 3, 2025  |  spacenews.comS
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
May 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/29/3090786/0/en/veraxa-biotech-to-attend-key-industry-conferences-to-showcase-bitac-technology-platform.html
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
May 29, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/29/3090517/0/en/veraxa-biotech-to-attend-key-industry-conferences-to-showcase-bitac-technology-platform.html
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
May 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/05/20/3085164/0/en/veraxa-biotech-appoints-rick-austin-as-chief-scientific-officer.html
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
May 20, 2025  |  manilatimes.netM
Voyager Acquisition Corp.: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
May 6, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-05/65309427-voyager-acquisition-corp-veraxa-biotech-enters-co-discovery-alliance-with-omniab-for-a-novel-bispecific-antibody-drug-conjugate-program-399.htm
VERAXA Biotech GmbH: VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
May 5, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-05/65297801-veraxa-biotech-gmbh-veraxa-biotech-enters-co-discovery-alliance-with-omniab-for-a-novel-bispecific-antibody-drug-conjugate-program-399.htm
Veraxa to go public in $1.6bn SPAC deal with Voyager
April 23, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/veraxa-to-go-public-in-16bn-spac-deal-with-voyager/ar-AA1DuQlG
VERAXA Biotech and Voyager Acquisition Corp. ...
April 23, 2025  |  gurufocus.comhttps://www.gurufocus.com/news/2796088/veraxa-biotech-and-voyager-acquisition-corp-announce-business-combination-agreement-to-create-nasdaqlisted-biopharmaceutical-company-advancing-a-pipeline-of-nextgeneration-cancer-therapies
VERAXA Biotech and Voyager Acquisition Corp. ...
April 23, 2025  |  gurufocus.comhttps://www.gurufocus.com/news/2796098/veraxa-biotech-and-voyager-acquisition-corp-announce-business-combination-agreement-to-create-nasdaqlisted-biopharmaceutical-company-advancing-a-pipeline-of-nextgeneration-cancer-therapies-vachu
Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal
April 23, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/veraxa-biotech-to-merge-with-spac-voyager-in-1-64-billion-deal/ar-AA1DqNTk
From Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQ
April 23, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/from-lab-to-unicorn-xlife-sciences-ag-portfolio-company-veraxa-biotech-ag-to-merge-with-voyager-acquisition-corp-listed-on-nasdaq-1034611319
Xlife Sciences’ VERAXA Biotech to Merge with Voyager Acquisition Corp.
April 23, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xlife-sciences-veraxa-biotech-to-merge-with-voyager-acquisition-corp?utm_source=marketbeat.com&utm_medium=referral
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination to Advance Next-Generation Cancer Therapies
April 23, 2025  |  quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

bleuacacia NASDAQ:BLEU

bleuacacia ltd does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of premium branded consumer retail. The company was incorporated in 2021 and is based in New York, New York.

Cantor Equity Partners III NASDAQ:CAEP

$10.55 +0.07 (+0.67%)
As of 08/1/2025 03:59 PM Eastern

We are a blank check company incorporated on November 11, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any discussions, directly or indirectly, with any business combination target regarding an initial business combination with our company. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including the financial services, digital assets, healthcare, real estate services, technology and software industries. Further, our efforts to identify a prospective target business will not be limited to any characteristics, although we expect to favor potential target companies with certain characteristics which include, but are not limited to, positive long term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement and attractive margins or the potential for attractive margins. Our executive offices are located New York, New York.

HCM II Acquisition stock logo

HCM II Acquisition NASDAQ:HOND

$10.81 -0.13 (-1.19%)
As of 08/1/2025 04:00 PM Eastern

HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.

Voyager Acquisition stock logo

Voyager Acquisition NASDAQ:VACH

$10.40 +0.02 (+0.19%)
As of 08/1/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Voyager Acquisition Corp. is a blank check company. It formed for the purpose of merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. Voyager Acquisition Corp. is based in BROOKLYN, N.Y.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas